84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]楊磊,崔宏勛,饒耀劍,等.彎角穿刺椎體成形裝置輔助下單側(cè)穿刺經(jīng)皮椎體成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折[J].中醫(yī)正骨,2020,32(01):64-68.
點擊復(fù)制

彎角穿刺椎體成形裝置輔助下單側(cè)穿刺經(jīng)皮椎體成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第32卷
期數(shù):
2020年01期
頁碼:
64-68
欄目:
臨床報道
出版日期:
2020-01-20

文章信息/Info

作者:
楊磊崔宏勛饒耀劍周英杰楊生民
(河南省洛陽正骨醫(yī)院/河南省骨科醫(yī)院,河南 洛陽 471002)
關(guān)鍵詞:
骨質(zhì)疏松性骨折 脊柱骨折 椎體成形術(shù) 彎角穿刺椎體成形裝置
摘要:
目的:探討彎角穿刺椎體成形裝置輔助下單側(cè)穿刺經(jīng)皮椎體成形術(shù)(percutaneous vertebroplasty,PVP)治療骨質(zhì)疏松性椎體壓縮骨折(osteoporotic vertebral compression fractures,OVCF)的臨床療效與安全性。方法:2018年1月至2019年1月采用彎角穿刺椎體成形裝置輔助下單側(cè)穿刺PVP治療OVCF患者30例。男12例,女18例。年齡52~83歲,中位數(shù)70歲。均為單個椎體骨折,T8骨折2例、T9骨折3例、T10骨折3例、T11骨折5例、T12骨折7例、L1骨折6例、L2骨折4例。骨密度T值-3.8~-2.6,中位數(shù)-3.2。記錄手術(shù)時間、出血量及骨水泥注入量。采用視覺模擬量表(visual analogue scale,VAS)和Oswestry功能障礙指數(shù)(Oswestry disability index,ODI)評價臨床療效。觀察骨水泥滲漏、神經(jīng)損傷、傷椎塌陷以及再骨折等并發(fā)癥的發(fā)生情況。結(jié)果:手術(shù)時間17~30 min,中位數(shù)23 min。術(shù)中出血量5~10 mL,中位數(shù)9 mL。骨水泥注入量3.5~6.8 mL,中位數(shù)4.6 mL。所有患者均獲隨訪,隨訪時間3~12個月,中位數(shù)8個月。患者腰背部疼痛VAS評分,術(shù)前(7.57±1.33)分,術(shù)后24 h(2.73±1.01)分,術(shù)后3個月(2.60±0.72)分,術(shù)后6個月(1.73±0.74)分; ODI,術(shù)前(57.93±9.43)%,術(shù)后24 h(28.13±6.82)%,術(shù)后3個月(20.90±4.13)%,術(shù)后6個月(19.97±2.14)%。1例患者發(fā)生骨水泥滲漏,滲漏位于椎體前方,未出現(xiàn)神經(jīng)損傷癥狀,故未予處理。至末次隨訪時,均未發(fā)生感染、神經(jīng)損傷、傷椎塌陷及再骨折。結(jié)論:彎角穿刺椎體成形裝置輔助下單側(cè)穿刺PVP治療OVCF,療效確切,骨水泥滲漏、傷椎塌陷及再骨折等并發(fā)癥少。

參考文獻/References:

[1] WATTS N B,HARRIS S T,GENANT H K.Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty[J].Osteoporos Int,2001,12(6):429-437.
[2] MARTIKOS K,GREGGI T,FALDINI C,et al.Osteoporotic thoracolumbar compression fractures:long-term retrospective comparison between vertebroplasty and conservative treatment[J].Eur Spine J,2018,27(Suppl 2):244-247.
[3] 顧力軍,董福慧.疼痛客觀化指標(biāo)在膝骨關(guān)節(jié)炎患者膝關(guān)節(jié)功能和疼痛評價中的應(yīng)用[J].中醫(yī)正骨,2013,25(9):22-24.
[4] 蔣協(xié)遠,王大偉.骨科臨床療效評價標(biāo)準(zhǔn)[M].北京:人民衛(wèi)生出版社,2005:119-121.
[5] 周宏,馬仁超.彎角椎體成形術(shù)與傳統(tǒng)PVP手術(shù)治療骨質(zhì)疏松性椎體壓縮骨折的療效對比[J].頸腰痛雜志,2019,40(2):194-196.
[6] 馬航展,馬金火,褚學(xué)遠,等.單側(cè)入路椎體成形術(shù)治療骨質(zhì)疏松性胸腰椎骨折[J].中國矯形外科雜志,2019,27(12):1068-1072.
[7] 龍淼.骨水泥彌散范圍對單側(cè)穿刺PVP術(shù)治療骨質(zhì)疏松性椎體壓縮性骨折療效的影響[J].頸腰痛雜志,2017,38(4):364-367.
[8] 賀雙軍,呂南寧,劉昊,等.經(jīng)皮椎體后凸成形術(shù)骨水泥分布形態(tài)對術(shù)后早期療效的影響[J].中華骨科雜志,2019,39(3):137-143.
[9] 謝華,李繼春,何勁,等.骨水泥分布對椎體成形手術(shù)后療效影響的研究[J].中華骨科雜志,2017,37(22):1400-1406.
[10] 鐘遠鳴,蘇之盟,覃海飚,等.椎體成形術(shù)骨水泥彌散情況對再發(fā)骨折的影響[J].重慶醫(yī)學(xué),2016,45(6):752-755.
[11] JENSEN M E,EVANS A J,MATHIS J M,et al.Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures:technical aspects[J].AJNR Am J Neuroradiol,1997,18(10):1897-1904.
[12] SAXENA A,HAKIMELAHI R,JHA R M,et al.The safety and effectiveness of a curved needle for vertebral augmentation:comparison with traditional techniques[J].J Vasc Interv Radiol,2010,21(10):1548-1553.
[13] 劉相英,劉建軍,李士民.應(yīng)用浸骨水泥明膠海綿預(yù)防經(jīng)皮椎體成形術(shù)中骨水泥滲漏[J].中醫(yī)正骨,2018,30(10):74-75.
[14] 張大鵬,毛克亞,強曉軍.彎角裝置單側(cè)穿刺經(jīng)皮椎體成形術(shù)治療Kümmell病的臨床療效[J].脊柱外科雜志,2017,15(6):335-338.

相似文獻/References:

[1]張亮,張莉,王莉佳,等.快速康復(fù)外科理念在椎弓根螺釘內(nèi)固定治療 胸腰椎骨折圍手術(shù)期護理中的應(yīng)用[J].中醫(yī)正骨,2015,27(06):75.
[2]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復(fù)鍛煉法對骨質(zhì)疏松性椎體壓縮 骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[3]宋永枝,陳雙玲.唑來膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療 骨質(zhì)疏松性長骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[4]孫蘭芬,王龍強,劉潤宏,等.頸椎骨折脫位合并脊髓損傷截癱患者的圍手術(shù)期護理[J].中醫(yī)正骨,2016,28(03):79.
[5]吳鵬,王博,孔令成,等.強骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
 WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):16.
[6]梅 偉.胸腰椎骨折臨床診療中的熱點問題[J].中醫(yī)正骨,2016,28(07):1.
[7]徐無忌,劉曉嵐.體位復(fù)位結(jié)合經(jīng)皮椎體成形術(shù)與經(jīng)皮椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折的對比研究[J].中醫(yī)正骨,2016,28(07):20.
 XU Wuji,LIU Xiaolan.Effect of Qianggu Yin(強骨飲,QGY)on bone microstructure in the ovariectomized osteoporosis rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[8]李英周,葉鋒,王曉,等.后路撬撥植骨椎弓根螺釘內(nèi)固定治療胸腰椎骨折[J].中醫(yī)正骨,2016,28(07):46.
[9]王軍,陳哲,王碩凡.胸腰椎骨折椎體植骨材料的臨床應(yīng)用進展[J].中醫(yī)正骨,2016,28(07):64.
[10]史曉林,王健,王博,等.脆性骨折的防治進展[J].中醫(yī)正骨,2017,29(05):20.
[11]陳建德,樊曉琦,夏炳江,等.球囊擴張部位對椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
 CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):11.
[12]丁志清,顏峰,喻燦明,等.椎體后凸成形術(shù)后非典型骨水泥植入綜合征死亡1例[J].中醫(yī)正骨,2017,29(11):76.
[13]俞興,王婷,楊濟洲,等.經(jīng)皮椎體成形術(shù)和經(jīng)皮椎體后凸成形術(shù)治療Kmmell病的對比研究[J].中醫(yī)正骨,2018,30(06):23.
 YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(01):23.
[14]彭小東,張曉剛,趙文韜,等.有限元分析在過伸復(fù)位治療骨質(zhì)疏松性椎體壓縮性骨折生物力學(xué)研究中的應(yīng)用進展[J].中醫(yī)正骨,2018,30(07):25.
[15]陳建德,樊曉琦,凌義龍.單側(cè)椎弓根旁外側(cè)入路與雙側(cè)椎弓根入路 經(jīng)皮椎體后凸成形術(shù)治療骨質(zhì)疏松性胸椎 壓縮性骨折的對比研究[J].中醫(yī)正骨,2018,30(10):19.
 CHEN Jiande,FAN Xiaoqi,LING Yilong.A retrospective trial of percutaneous kyphoplasty through unilateral extrapedicular approach versus bilateral transpedicular approach for treatment of thoracic osteoporotic vertebral compression fracture[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(01):19.
[16]于東方,王祥善,張華,等.經(jīng)皮椎體成形術(shù)后手術(shù)椎體再骨折的病因、治療及預(yù)防[J].中醫(yī)正骨,2018,30(10):69.
[17]李兆勇,楊少鋒,張晨陽.補腎活血方聯(lián)合經(jīng)皮椎體強化術(shù)治療骨質(zhì)疏松性椎體壓縮骨折的系統(tǒng)評價[J].中醫(yī)正骨,2019,31(03):28.
 LI Zhaoyong,YANG Shaofeng,ZHANG Chenyang.Oral application of Bushen Huoxue Fang(補腎活血方)combined with percutaneous vertebral augmentation for treatment of osteoporotic vertebral compression fractures:a systematic review[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(01):28.
[18]陳晨,安忠誠,張英健,等.椎體強化術(shù)后殘留腰背痛的研究進展[J].中醫(yī)正骨,2020,32(05):26.
[19]劉銳,龔德飛,班正濤,等.經(jīng)皮椎體成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折術(shù)中骨水泥滲漏的危險因素分析[J].中醫(yī)正骨,2022,34(11):14.
 LIU Rui,GONG Defei,BAN Zhengtao,et al.Risk factors for bone cement leakage during percutaneous vertebroplasty treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(01):14.
[20]羅金金,丁彩田.骨質(zhì)疏松性椎體壓縮骨折經(jīng)皮椎體后凸成形術(shù)后脊柱后凸畸形改善程度的影響因素分析[J].中醫(yī)正骨,2022,34(08):8.
 LUO Jinjin,DING Caitian.Analysis of factors influencing the degree of improvement of spinal kyphosis deformity after percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fracture[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2022,34(01):8.

備注/Memo

備注/Memo:
(收稿日期:2019-08-14 本文編輯:李曉樂)基金項目:河南省中醫(yī)藥科學(xué)研究專項課題(2019ZY2091); 河南省青苗人才培養(yǎng)項目(豫中醫(yī)科教[2018]16號)通訊作者:崔宏勛 E-mail:[email protected]
更新日期/Last Update: 2020-01-15